Core Points - NexMetals Mining Corp. has filed a final short form prospectus for a public offering of up to 14,035,100 units at a price of $5.70 per unit, aiming for gross proceeds of up to $80,000,070 [1][2] - The closing of the offering is anticipated to occur on November 17, 2025, with conditional approval from the TSX Venture Exchange [2] - The final prospectus is accessible on SEDAR+ and can be obtained from SCP Resource Finance LP [3] Company Overview - NexMetals Mining Corp. is focused on the redevelopment of previously producing copper, nickel, and cobalt mines in Botswana [5] - The company emphasizes governance through transparent accountability and has a team with extensive experience in mine discovery and development [6]

Core Insights - Zedcor Inc. reported record quarterly revenue of $16.0 million and Adjusted EBITDA of $5.7 million for Q3 2025, marking a 75% year-over-year increase in revenue and a 68% increase in Adjusted EBITDA [5][8][10] Financial Performance - Revenue for Q3 2025 was $16.0 million, up from $9.2 million in Q3 2024, reflecting a 75% increase year-over-year and an 18% increase quarter-over-quarter [5][8][9] - Adjusted EBITDA for the same period was $5.7 million, compared to $3.4 million in Q3 2024, representing a 68% increase [5][10] - The Adjusted EBITDA margin was 36%, driven by strong contribution margins in Canada and continued growth in the US [5][10] Operational Highlights - The company deployed 469 new MobileyeZTM security towers in Q3 2025, bringing the total fleet to 2,351 towers, with a focus on US expansion [5][15] - The US market accounted for 36% of total revenue in Q3 2025, with strong demand for security towers and ongoing conversations with enterprise customers [3][5] - Fleet utilization rates remained strong, indicating effective operational management and customer demand [5][11] Strategic Initiatives - Zedcor is expanding its operations in the US, particularly in major Texas cities and other southern US markets, to meet growing demand for its services [15][24] - The company is diversifying its customer base across various industries, reducing reliance on any single customer [15][24] - Continued investment in manufacturing capabilities has allowed Zedcor to produce security towers at an increased rate, with a focus on managing supply chains effectively [15][26][27] Market Outlook - The company anticipates sustained growth driven by increased infrastructure spending and rising incidents of theft and vandalism across North America [24][26] - Zedcor's innovative technology and commitment to customer service position it well to disrupt the traditional security industry [24][26] - The company aims to maintain a Net Funded Debt to EBITDA ratio of no more than 3.00:1.00 and a Fixed Charge Coverage Ratio of no less than 1.15:1.00 [25]

Core Viewpoint - Rosen Law Firm is encouraging investors of aTyr Pharma, Inc. to secure legal counsel before the December 8, 2025 deadline for a securities class action related to the company's stock performance during the specified class period [2][4]. Group 1: Class Action Details - Investors who purchased aTyr Pharma common stock between January 16, 2025, and September 12, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - The lawsuit claims that aTyr Pharma provided misleading statements regarding the efficacy of its drug Efzofitimod, particularly concerning its ability to allow patients to taper steroid usage completely [6]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [5]. Group 3: Next Steps for Investors - To join the class action, investors can visit the provided link or contact the law firm directly for more information [4][7]. - It is noted that no class has been certified yet, and investors are not represented unless they retain counsel [8].

Core Points - Eric Sprott's corporation, 2176423 Ontario Ltd., acquired 249,300 common shares of Maritime Resources Corp, representing approximately 0.2% of the outstanding shares at an average price of $2.20 per share for a total of about $549,208 [1] - Following this acquisition, Mr. Sprott's total beneficial ownership increased to 10,255,000 shares and 2,666,700 warrants, representing approximately 8.3% of the outstanding shares on a non-diluted basis and 10.2% on a partially diluted basis [2] - The shares were acquired for investment purposes, with a long-term view, and Mr. Sprott may consider acquiring additional securities or selling existing ones based on market conditions [3]

Core Points - Austral Gold Limited has issued 7,789,471 fully paid ordinary shares to an investor following the conversion of outstanding convertible notes [1][2] - The principal amount of the convertible notes was AUD$919,158 (approximately US$599,383) and convertible at AUD$0.118 per share [2] - The company plans to convert outstanding interest due under the notes into shares, which could result in an additional issuance of 1,025,077 shares, pending approval [3] Summary by Sections Share Issuance - The conversion of the principal amount resulted in the issuance of 7,789,471 shares, which are not subject to a statutory hold period in Canada [4] - If the interest conversion is approved, the total shares issued to the note holder will amount to 8,814,548, representing approximately 1.42% of the company's total issued shares [5] Financial Details - The convertible notes had a principal amount of AUD$919,158, convertible at a price of AUD$0.118 per share [2] - The outstanding interest due under the notes, amounting to AUD$120,959 (approximately US$78,877), will also be converted into shares at the same price [3] Company Overview - Austral Gold is focused on building a portfolio of quality gold and silver mining assets in the Americas, emphasizing production, exploration, and equity investments [6]

Core Points - Moss Genomics Inc. has completed a non-brokered private placement of 555,555 common shares at a price of $0.18 per share, raising gross proceeds of $100,000 [1] - The company also issued 5,164,213 common shares at a deemed price of $0.18 per share as part of asset purchase agreements, acquiring approximately 224.7523 ETH at an average price of $3,833 per ETH, totaling $966,435 [2] - Following these transactions, Moss has a total of 63,414,545 common shares issued and outstanding [3] - An Annual and Special General Meeting is scheduled for November 13, 2025, to be conducted virtually [4] Company Overview - Moss Genomics is focused on developing a secure platform for genomic data, allowing individuals to manage their DNA and participate in research monetization [5] - The company utilizes Ethereum-based infrastructure, with ETH funding development, DNA sequencing services, and future operations [5] - The mission of Moss Genomics is to advance decentralized and privacy-preserving genomics through practical applications in health, identity, and research [5]

Core Points - Chesapeake Gold Corp has completed the sale of its Tatatila gold-copper project in Veracruz, Mexico to Mexican Gold Mining Corp, acquiring 4,451,361 common shares, representing 14.99% of Mexican Gold's outstanding shares [1][2] - In addition to the shares, Chesapeake received a 1.5% net smelter return royalty, which Mexican Gold can repurchase for U.S.$500,000 within ten years [2] - The acquired shares are subject to a lock-up period, with 25% being released every six months, fully releasing the shares after 2.5 years [3] Company Actions - Chesapeake acquired the shares for investment purposes and will monitor Mexican Gold's business and financial condition, with potential plans to acquire or sell additional securities in the future [4] - An early warning report regarding the transaction will be filed on SEDAR+ [5] Company Overview - Chesapeake Gold's flagship asset is the Metates Project in Durango State, Mexico, which contains over 16.77 million ounces of gold and 423.2 million ounces of silver in the Measured and Indicated Mineral Resource category [6]

Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Mexican Gold Mining Corp. (TSXV: MEX) (OTCQB: MEXGF) (the "Company" or "Mexican Gold") is pleased to announce that, pursuant to a mining concessions assignment agreement (the "Assignment Agreement") between the Company and its subsidiary, Roca Verde Exploración de México, S.A. de C.V. ("Roca Verde"), with Chesapeake Gold Corp. ("Chesapeake") and its subsidiaries Minerales El Prado, S.A. de C.V. ("MEP") and Chesapeake México, S.A. de C.V. ( ...

Core Insights - Medexus Pharmaceuticals reported strong performance in fiscal Q2 2026, primarily driven by GRAFAPEX (treosulfan) for Injection, with product-level net revenue reaching $3.1 million and $6.2 million for the three- and six-month periods ended September 30, 2025, respectively [2][4][9] - The company experienced a decrease in overall net revenue, attributed to reduced sales of Rupall and Gleolan, but GRAFAPEX's performance is expected to positively impact future cash flows [4][5][6] Financial Performance - Total net revenue for fiscal Q2 2026 was $24.7 million, down 6.1% from $26.3 million in the prior year, while six-month revenue decreased by 7.8% to $49.4 million [4][5] - Adjusted EBITDA for the three- and six-month periods was $4.4 million and $7.8 million, representing a decrease of 26.7% and 35.5% year-over-year, respectively [5][6] - Operating income was reported at $1.4 million and $2.2 million for the three- and six-month periods, reflecting a decrease of 12.5% and 60.7% compared to the previous year [7] Product Performance - GRAFAPEX has shown strong market demand, with 83% of US transplant centers engaged and 29% having ordered the product [3][9] - The company anticipates that GRAFAPEX will exceed $100 million in annual product-level net revenue within five years post-launch, supported by recent NTAP reimbursement approvals [8][9] - Patient unit demand for Trecondyv increased by 69% over the trailing 12 months, while IXINITY saw a slight decrease of 3% [10][11] Operational Highlights - Medexus has successfully reduced total debt by $16.6 million since March 31, 2025, bringing total long-term debt to $21.1 million as of September 30, 2025 [6][7] - The company generated $3.3 million in cash flow from operating activities for fiscal Q2 2026, despite a decrease from the previous year [6][7] - GRAFAPEX's launch has been supported by significant investments in personnel and infrastructure, totaling $6.0 million through September 30, 2025 [2][3]

Core Viewpoint - Seabridge Gold reported a net loss for Q3 2025, while increasing investments in mineral interests and improving net working capital compared to the previous year [3][4]. Financial Results - Seabridge Gold posted a net loss of $32.3 million ($0.32 per share) for the three-month period ended September 30, 2025, compared to a net loss of $27.6 million ($0.31 per share) for the same period last year [3]. - The company invested $52.9 million in mineral interests during Q3 2025, up from $28.1 million in Q3 2024 [3]. - As of September 30, 2025, Seabridge's net working capital was $83.2 million, an increase from $37.8 million at December 31, 2024 [3]. Company Assets - Seabridge Gold holds a 100% interest in several North American gold projects, including the KSM and Iskut projects in Northwest British Columbia, the Courageous Lake project in the Northwest Territories, the Snowstorm project in Northern Nevada, and the 3 Aces project in the Yukon Territory [4]. Operational Updates - KSM field activities and partnership discussions are ongoing, with a 24,000 meter drill program at Iskut in 2025 confirming a new large porphyry deposit at Snip North [7]. - Court hearings have been completed on petitions challenging KSM's substantially started designation, with three additional challenges filed by Tudor Gold against KSM's Mitchell-Treaty-Tunnel authorizations [7]. - The 2025 exploration program at the 3 Aces project has been completed [7].